Low BCL6 expression predicted poor survival in both tumor size groups (TMD < 5 cm: P = 0.013; TM≧5 cm: P = 0.049, Fig. 1G) and pN0 subgroups (P = 0.003, Fig. 1H). Here, BCL6 is linked to neoplasm.